Skip to main content
menu toggle button
What we do
Main menu
Capabilities
Capabilities
Our Integrated Model
Commercialization
3PL and Importation
Regulatory services
Consulting services
Patient support programs
Clinics and nursing
Pharmacovigilance
Specialty Distribution
Pharmacy
Solutions
Solutions
Corporate Wellness programs
Digital Health Solutions
Innomar Pharmacy
Innomar Clinics
Who we are
Main menu
About us
Our leadership team
Corporate citizenship
INSIGHTS
NEWS & EVENTS
CAREERS
Find a clinic
Contact us
language picker toggle button
English
English
Français
search toggle button
Find a clinic
Contact us
INSIGHTS
NEWS & EVENTS
CAREERS
language picker toggle button
English
English
Français
Insights
Filter By
All Topics
Affordability
Analytics
Biosimilars
Commercialization
COVID-19
Data
Digital Solutions
Distribution
Legislation
Market access
Medical Device
Medication adherence
Medication therapy management
Oncology
Our role in healthcare
Patient care
Patient support services
Policy
Product access
Regulatory
Reimbursement
Research
Specialty pharmacy
Technology
Third-party logistics
Sort By
Date (Newest to Oldest)
Date (Oldest to Newest)
Title (A-Z)
Title (Z-A)
Filter
Innomar Strategies
Webinar on-demand - A Panel Discussion on Navigating Medical Devices in Canada
Innomar Strategies
July 2024
Manufacturers
Drug development checklist: what to look for in a commercialization partner
Innomar Strategies
April 2024
Manufacturers
Pre-launch checklist: what to look for in a commercialization partner
Innomar Strategies
April 2024
Manufacturers
Post launch checklist: what to look for in a commercialization partner
Innomar Strategies
April 2024
Manufacturers
InnomarLive 2023: Part One
Innomar Strategies
April 2023
Manufacturers
InnomarLive 2023: Part Two
Innomar Strategies
April 2023
Manufacturers
InnomarLive 2023: Part Three
Innomar Strategies
April 2023
Manufacturers
Reuters Cell & Gene Therapy USA 2022 – RWE for Market Access
Innomar Strategies
February 2023
Manufacturers
Innomar Strategies: 20 years of innovative market access solutions
Innomar Strategies
June 2021
Manufacturers
The value of Real-World Evidence in Canadian drug commercialization: Part 2
Innomar Strategies
April 2021
Manufacturers
Webinar: Utilizing Real World Evidence Across the Product Life Cycle
Innomar Strategies
June 2020
Manufacturers
Market Access: Reimbursement
Innomar Strategies
June 2020
Manufacturers
InnomarLive 2019: Commercializing in Canada
Innomar Strategies
December 2019
Infographic: The Route to Market Access in Canada
Innomar Strategies
May 2018
Infographic: The Road to Commercialization in Canada
Innomar Strategies
May 2018
Insight Series: Biosimilars in Canada
Innomar Strategies
January 2018
Future of Patient Support Programs in Canada
Sandra Anderson
Commercialization and Strategy
June 2016
Explore More by Topic
Affordability
Analytics
Biosimilars
Commercialization
COVID-19
Data
brand="Cencora" culture="EN" env="Production" tracker="False"
